Retrieve available abstracts of 390 articles: HTML format
Single Articles
July 2025
RUMFELT KE, Juntila C, Smith M, Callear A, et al Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin
G Following Infection and Exposure in a Household Cohort, 2014-2022.
J Infect Dis. 2025;231:e1138-e1145. PubMedAbstract available
HEDBERG P, Serwin K, Francesca Greco M, P V Pereira J, et al Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19
Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project.
J Infect Dis. 2025;231:e1091-e1101. PubMedAbstract available
NGUYEN BT, Bertrand J, Agyeman AA, Zhang S, et al A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in
Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration.
J Infect Dis. 2025;231:e1080-e1090. PubMedAbstract available
MANUELPILLAI B, Lopman B, Doran CR, Porter C, et al The Impact of Coronavirus Disease 2019 Nonpharmaceutical Interventions on
Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US
Military and Dependents.
J Infect Dis. 2025;231:e1075-e1079. PubMedAbstract available
BARTSCH SM, Chin KL, Strych U, John DC, et al The Current and Future Burden of Long COVID in the United States.
J Infect Dis. 2025;231:1581-1590. PubMedAbstract available
WHITE CL, Richards KA, Huertas N Jr, Nayak JL, et al Human HKU1-Reactive CD4 T Cells Are Enriched for Cytolytic Potential That
Persists in Older Adults.
J Infect Dis. 2025;231:1591-1596. PubMedAbstract available
OKABE H, Hashimoto K, Norito S, Asano Y, et al Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in
Fukushima, Japan, During 2008-2023 and Their Effects.
J Infect Dis. 2025;231:1544-1552. PubMedAbstract available
HALL VG, Nguyen THO, Smibert OC, Allen LF, et al Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying
Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.
J Infect Dis. 2025 Jul 2:jiaf297. doi: 10.1093. PubMedAbstract available
June 2025
GUILFOYLE K, Mirolo M, de Waal L, van Amerongen G, et al Highly Pathogenic Avian Influenza Virus A/H5N1 subclade 2.3.4.4 b isolated from a
European grey seal (Halichoerus grypus) is highly virulent in ferrets.
J Infect Dis. 2025 Jun 28:jiaf348. doi: 10.1093. PubMedAbstract available
LU Y, Allen JD, Ross TM, Cowling B, et al Evaluating the Breadth and Reliability of Influenza Vaccine Protection
Indicators: a Secondary Analysis of an Animal Challenge Trial.
J Infect Dis. 2025 Jun 20:jiaf331. doi: 10.1093. PubMedAbstract available
KING LM, Bruxvoort KJ, Tartof SY, Lewnard JA, et al Pediatric antibiotic use associated with respiratory syncytial virus and
influenza in the United States, 2008-2018.
J Infect Dis. 2025 Jun 7:jiaf309. doi: 10.1093. PubMedAbstract available
REICHERZ F, Vineta Paramo M, Bone JN, Lavoie A, et al Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus
Infections.
J Infect Dis. 2025;231:e840-e845. PubMedAbstract available
BAUMGARDT M, Obermayer B, Balazs A, Lowa A, et al SARS-CoV-2 Infection of Human Lung Air-Liquid Interface Cultures Reveals Basal
Cells as Relevant Targets.
J Infect Dis. 2025;231:1210-1220. PubMedAbstract available
DI GERMANIO C, Marques de Menezes EG, Clevenger R, Rines I, et al Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of
Convalescent Plasma.
J Infect Dis. 2025;231:1198-1209. PubMedAbstract available
LENNOL MP, Garcia-Ayllon MS, Aviles-Granados C, Trasciatti C, et al Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a
Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy.
J Infect Dis. 2025;231:e929-e940. PubMedAbstract available
ZIDAR DA, McComsey GA, Anthony DD, McDaniel J, et al Distinct Cytokine Patterns Identify Acute and Convalescent Myocardial Involvement
After Coronavirus Disease 2019: A Multicohort Biomarker Study.
J Infect Dis. 2025;231:e918-e920. PubMedAbstract available
RIEDMANN U, Chalupka A, Richter L, Sprenger M, et al Estimates of SARS-CoV-2 Infections and Population Immunity After the COVID-19
Pandemic in Austria: Analysis of National Wastewater Data.
J Infect Dis. 2025;231:e921-e928. PubMedAbstract available
URCHUEGUIA-FORNES A, Munoz-Quiles C, Mira-Iglesias A, Lopez-Lacort M, et al Ten-Year Surveillance of Respiratory Syncytial Virus Hospitalizations in Adults:
Incidence Rates and Case Definition Implications.
J Infect Dis. 2025;231:e830-e839. PubMedAbstract available
HOUDE L, Law AW, Averin A, Weycker D, et al Annual Clinical and Economic Burden of Medically Attended Lower Respiratory Tract
Illnesses Due to Respiratory Syncytial Virus Among US Infants Aged <12 Months.
J Infect Dis. 2025;231:1318-1326. PubMedAbstract available
OZTURK A, Chan M, Khan JR, Hu N, et al Clinical Characteristics and In-hospital Outcomes Associated With Respiratory
Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized
Children Younger Than 2 Years.
J Infect Dis. 2025;231:1309-1317. PubMedAbstract available
May 2025
ZHU S, Quint J, Leon T, Sun M, et al Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza
Using Linked Public Health Information Systems, California, 2023-2024 Season.
J Infect Dis. 2025 May 13:jiaf248. doi: 10.1093. PubMedAbstract available
April 2025
FURMANSKI M, Murcia PR Did horses act as intermediate hosts that facilitated the emergence of 1918
pandemic influenza?
J Infect Dis. 2025 Apr 22:jiaf197. doi: 10.1093. PubMedAbstract available
CORTIER T, Gilboa M, Layan M, Joseph G, et al Factors Associated With the Transmission of the Delta Severe Acute Respiratory
Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study
(ICoFS).
J Infect Dis. 2025;231:e734-e742. PubMedAbstract available
KOZANLI E, Winkel AMAM, Han AX, van den Brink S, et al Shortened SARS-CoV-2 Viral RNA Shedding in Saliva During Early Omicron Compared
to Wild-Type Pandemic Phase.
J Infect Dis. 2025;231:940-945. PubMedAbstract available
DOLANGE V, Slamanig S, Abdeljawad A, Lai TY, et al A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human
Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe
Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
J Infect Dis. 2025;231:e723-e733. PubMedAbstract available
ALESSANDRINI J, Smith BT, Fitzpatrick T, Buchan SA, et al Socioeconomic Inequities in the Age-Specific Burden of Severe Respiratory
Syncytial Virus in Canada, 2016-2019.
J Infect Dis. 2025;231:e626-e637. PubMedAbstract available
JACOBS MB, Clark AE, Goldhaber NH, Valentine HD, et al Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike
Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays
Correlate With COVID-19 Infection Risk in a Large Population.
J Infect Dis. 2025;231:921-930. PubMedAbstract available
SANKARANARAYANAN R, Ha B, Sun H, Liu K, et al Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory
Syncytial Virus Infection in Infants and Young Children.
J Infect Dis. 2025;231:1060-1068. PubMedAbstract available
CHO HK, Frivold C, Chu HY Maternal Immunization.
J Infect Dis. 2025;231:830-836. PubMedAbstract available
CHUN A, Bautista-Castillo A, Osuna I, Nasto K, et al Distinguishing Multisystem Inflammatory Syndrome in Children From Typhus Using
Artificial Intelligence: MIS-C Versus Endemic Typhus (AI-MET).
J Infect Dis. 2025;231:931-939. PubMedAbstract available
MORRIS SE, Mathis SM, Reeves E, Chung JR, et al Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing
Influenza-Associated Hospitalizations in the United States.
J Infect Dis. 2025 Apr 12:jiaf061. doi: 10.1093. PubMedAbstract available
YAMAMOTO S, Mizoue T, Ujiie M, Horii K, et al Low levels of post-vaccination hemagglutination inhibition antibodies and their
correlation with influenza protection among healthcare workers during the
2024/2025 A/H1N1 outbreak in Japan.
J Infect Dis. 2025 Apr 10:jiaf183. doi: 10.1093. PubMedAbstract available
LEWIS NM, Harker EJ, Cleary S, Zhu Y, et al Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated
Hospitalizations-United States, September 1, 2023-May 31, 2024.
J Infect Dis. 2025 Apr 8:jiaf185. doi: 10.1093. PubMedAbstract available
March 2025
FRUTOS AM, Tenforde MW, Sundaresan D, Naleway AL, et al Influenza-associated hospitalization rates by underlying conditions, 2016-17 to
2019-20: A retrospective cohort study.
J Infect Dis. 2025 Mar 28:jiaf164. doi: 10.1093. PubMedAbstract available
CAO W, Su W, Song X, Ma L, et al Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated
Influenza Infection in Adults: A Multicenter Randomized, Double-Blind,
Placebo-Controlled Phase 2 Trial.
J Infect Dis. 2025 Mar 25:jiaf075. doi: 10.1093. PubMedAbstract available
WALSH EE, Peasley M, Branche A, Falsey AR, et al Respiratory Syncytial Virus (RSV) Humoral Antibody Responses in Older Adults
after Vaccination or Infection.
J Infect Dis. 2025 Mar 24:jiaf149. doi: 10.1093. PubMedAbstract available
ROSTAD CA, Campbell JD, Paulsen GC, Schnyder Ghamloush S, et al Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6
Months to 11 Years of Age.
J Infect Dis. 2025 Mar 22:jiaf144. doi: 10.1093. PubMedAbstract available
WONG JY, Cheung JK, Presanis AM, De Angelis D, et al Assessing the impact of influenza epidemics in Hong Kong.
J Infect Dis. 2025 Mar 19:jiaf140. doi: 10.1093. PubMedAbstract available
QUACH HQ, Goergen KM, Grill DE, Ovsyannikova IG, et al IL-8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in
Older Adults.
J Infect Dis. 2025 Mar 17:jiaf148. doi: 10.1093. PubMedAbstract available
MENG Y, Lin Y, Xiong W, Lau EHY, et al Effective Real-time Transmission Estimations Incorporating Population Viral Load
Distributions Amid SARS-CoV-2 Variants and Preexisting Immunity.
J Infect Dis. 2025;231:684-691. PubMedAbstract available
MADHI SA, Simoes EAF, Acevedo A, Novoa Pizarro JM, et al A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus
Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
J Infect Dis. 2025;231:e478-e487. PubMedAbstract available
THAMBI N, Phuah JY, Staupe RP, Tobias LM, et al Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab
Trial Are Associated With RSV Exposure Beyond Day 150.
J Infect Dis. 2025;231:e488-e496. PubMedAbstract available
PROBOSTE T, Bista D, Clark NJ, Arora S, et al Ascertainment of Community Exposure Sites to Ross River Virus During the 2020
Outbreak in Brisbane, Australia.
J Infect Dis. 2025;231:e501-e510. PubMedAbstract available
WINKEL AMAM, Kozanli E, Haverkort ME, Euser SM, et al Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern
vs Wild Type: An Interplay Between Transmissibility and Immune Status.
J Infect Dis. 2025;231:653-664. PubMedAbstract available
REILLY C, Mylonakis E, Dewar R, Young B, et al Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for
Biomarker-Guided Management of Coronavirus Disease 2019.
J Infect Dis. 2025;231:677-683. PubMedAbstract available
MONTO AS, Foster-Tucker JE, Callear AP, Leis AM, et al Respiratory Viral Infections From 2015 to 2022 in the HIVE Cohort of American
Households: Incidence, Illness Characteristics, and Seasonality.
J Infect Dis. 2025;231:795-804. PubMedAbstract available
HEDBERG P, van der Werff SD, Naucler P The effect of COVID-19 vaccination on the risk of persistent post COVID-19
condition: Cohort study.
J Infect Dis. 2025 Mar 12:jiaf133. doi: 10.1093. PubMedAbstract available
VILLALOBOS RODRIGUEZ AP, Wellington Perkins I, Moosavi S, de la Garza A, et al Pandemic Preparedness: Analyzing National Plans for Respiratory Pathogen
Pandemics in the Americas Region.
J Infect Dis. 2025;231. PubMedAbstract available
REDONDO-BRAVO L, Zureick K, Voto C, Molina Avendano X, et al A Comparative Analysis of Universal and Sentinel Surveillance Data for
Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020-2022).
J Infect Dis. 2025;231. PubMedAbstract available
RODRIGUEZ A, Couto P, Acevedo A, Herrera BA, et al Strengthening the Surveillance and Response to Public Health Events With a One
Health Approach: A Perspective From 12 Countries in Latin America and the
Caribbean.
J Infect Dis. 2025;231. PubMedAbstract available
February 2025
HUANG QS, Wood T, Aminisani N, Kvalsvig A, et al Comparison of the incidence and risk factors of COVID-19 and influenza associated
acute respiratory illnesses: Results of the SHIVERS-II, III, IV prospective
community cohort study.
J Infect Dis. 2025 Feb 24:jiaf097. doi: 10.1093. PubMedAbstract available
LEVENE RE, DeVincenzo J, Conery AL, Ahmad A, et al EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally
Infected with Respiratory Syncytial Virus.
J Infect Dis. 2025;231:e290-e298. PubMedAbstract available
Correction to: An Update on Highly Pathogenic Avian Influenza A(H5N1) Virus,
Clade 2.3.4.4b.
J Infect Dis. 2025 Feb 17:jiaf085. doi: 10.1093. PubMed
GUEZALA MC, Schilling MA One Health Networks for Infectious Diseases Surveillance and Pandemic
Preparedness in Central and South America.
J Infect Dis. 2025;231. PubMedAbstract available
SOTO G, Romero C, Gonzales M, La Rosa S, et al Influenza Virus Surveillance in Healthcare Personnel in Peru: NAMRU SOUTH
Experience and Perspective.
J Infect Dis. 2025;231. PubMedAbstract available
LORENZ N, James A, Van Rooyen T, Paterson A, et al Decline of Antibodies to Major Viral and Bacterial Respiratory Pathogens During
the COVID-19 Pandemic.
J Infect Dis. 2025;231:e77-e81. PubMedAbstract available
CHEW KW, McGinley B, Moser C, Li JZ, et al Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome
Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled
Trial.
J Infect Dis. 2025;231:131-136. PubMedAbstract available
BONOMO EJ, Shah M Rights-Based Legal Considerations for Tuberculosis Isolation Practices in
Community Settings in the Postpandemic Era.
J Infect Dis. 2025;231:31-36. PubMedAbstract available
PISANIC N, Antar AAR, Hetrich MK, Demko ZO, et al Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid
Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom
Resolution.
J Infect Dis. 2025;231:121-130. PubMedAbstract available
NAIR MS, Luck MI, Huang Y, Sabo Y, et al Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor
Treatment of Permissive Cells In Vitro.
J Infect Dis. 2025;231:e68-e76. PubMedAbstract available
BARZAGHI F, Visconti C, Pipitone GB, Bondesan S, et al Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2
Infections in a Patient With Thymoma and Anti-Type I Interferon Antibodies.
J Infect Dis. 2025;231:e206-e212. PubMedAbstract available
GOYA S, Wendm ST, Xie H, Nguyen TV, et al Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State,
2021-2022.
J Infect Dis. 2025;231:e154-e164. PubMedAbstract available
JARA JH, Loayza S, Nogareda F, Couto P, et al Influenza vaccine averted illnesses in Chile, Guyana, and Paraguay during
2013-2018: a standardized approach to assess value of vaccination.
J Infect Dis. 2025 Feb 1:jiaf038. doi: 10.1093. PubMedAbstract available
DESCALZO MA, de Paula Junior FJ, Mallegas NV, Penayo E, et al Annual estimation of seasonal influenza burden in six South American countries: a
retrospective analysis of SARInet surveillance data to inform policies.
J Infect Dis. 2025 Feb 1:jiaf037. doi: 10.1093. PubMedAbstract available
January 2025
CHALKIAS S, Pragalos A, Akinsola A, Berman G, et al Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain
andN-Terminal Domain mRNA Vaccine.
J Infect Dis. 2025 Jan 10:jiaf022. doi: 10.1093. PubMedAbstract available
KOIRALA A, Smith K, Britton PN, Howard-Jones AR, et al Protracted Tuberculosis Outbreak in a Pasifika Diaspora in Western Sydney,
Australia: The Importance of Community Engagement.
J Infect Dis. 2025 Jan 9:jiae619. doi: 10.1093. PubMedAbstract available
BILLINGS WZ, Ge Y, Knight JH, Hemme H, et al High dose inactivated influenza vaccine inconsistently improves heterologous
antibody responses in an elderly human cohort.
J Infect Dis. 2025 Jan 8:jiaf003. doi: 10.1093. PubMedAbstract available
FELDSTEIN LR, Ruffin J, Wiegand RE, Borkowf CB, et al Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing
SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093. PubMedAbstract available
December 2024
ANDERSON EJ, Tippett A, Begier E, Gibson T, et al Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory
Syncytial Virus in Hospitalized Adults in the United States.
J Infect Dis. 2024;230:1342-1351. PubMedAbstract available
DOTY B, Ghaswalla P, Bohn RL, Stoszek SK, et al Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and
Critical Gaps in Information.
J Infect Dis. 2024;230:e1182-e1201. PubMedAbstract available
ANDRES C, Perramon-Malavez A, Creus-Costa A, Gatell A, et al Respiratory Viral Coinfections in Pediatric Patients in the Primary Care Setting:
A Multicenter Prospective Study Within the COPEDICAT Network.
J Infect Dis. 2024;230:1337-1341. PubMedAbstract available
HAMMERTON SM, Billings WZ, Hemme H, Ross TM, et al Estimating standard-dose and high-dose Fluzone vaccine efficacies for influenza A
based on HAI titers.
J Infect Dis. 2024 Dec 13:jiae615. doi: 10.1093. PubMedAbstract available
WANG J, Genberg BL, Feder K, Kirk GD, et al Impact of pandemic-induced service disruptions and behavioral changes on HCV and
HIV transmission amongst people who inject drugs: a modeling study.
J Infect Dis. 2024 Dec 6:jiae599. doi: 10.1093. PubMedAbstract available
November 2024
KANG HM, Kim HJ, Jung J, Ahn JY, et al Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the
Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study.
J Infect Dis. 2024 Nov 29:jiae536. doi: 10.1093. PubMedAbstract available
BIDDLE JE, Nguyen HQ, Talbot HK, Rolfes MA, et al Asymptomatic and mildly symptomatic influenza virus infections by season
--Case-ascertained household transmission studies, United States, 2017-2023.
J Infect Dis. 2024 Nov 27:jiae591. doi: 10.1093. PubMedAbstract available
BRANCHE AR, Falsey AR, Finelli L, Walsh EE, et al Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory
Syncytial Virus Hospitalization.
J Infect Dis. 2024;230:e1007-e1011. PubMedAbstract available
BLAIR PW, Siddharthan T, Herrera PM, Cui E, et al Validation of Lung Ultrasound for Coronavirus Disease 2019 Prognostication in an
International Multicenter Cohort Study.
J Infect Dis. 2024;230:e1092-e1100. PubMedAbstract available
CHEW KW, Taiwo BO, Moser C, Daar ES, et al Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A
Randomized Clinical Trial.
J Infect Dis. 2024;230:1177-1186. PubMedAbstract available
LEVY ME, Chilunda V, Davis RE, Heaton PR, et al Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute
Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant.
J Infect Dis. 2024;230:1197-1201. PubMedAbstract available
HARDING ER, Wildenbeest JG, Heikkinen T, Dacosta-Urbieta A, et al Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of
Children Aged <2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2
Pandemic: A Retrospective Multicenter Study in 4 European Countries.
J Infect Dis. 2024;230:e985-e995. PubMedAbstract available
COHEN C, du Plessis M, Martinson N, Moyes J, et al A potential platform for future vaccine trials identifies high incidence of
symptomatic and asymptomatic influenza infection among children aged 6-23 months
in South Africa.
J Infect Dis. 2024 Nov 14:jiae550. doi: 10.1093. PubMedAbstract available
MAK J, Khan S, Britton A, Rose S, et al Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions
following SARS-CoV-2 infection in a US prospective cohort of essential workers.
J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093. PubMedAbstract available
YEGOROV S, Brewer A, Cyr L, Ward BJ, et al Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited
by Inactivated and Live Attenuated Vaccines in Children.
J Infect Dis. 2024 Nov 6:jiae489. doi: 10.1093. PubMedAbstract available
ALARCON PC, Ulanowicz CJ, Damen MSMA, Eom J, et al Obesity uncovers presence of inflammatory lung macrophage subsets with adipose
tissue transcriptomic signature in influenza virus infection.
J Infect Dis. 2024 Nov 4:jiae535. doi: 10.1093. PubMedAbstract available
October 2024
MAVIAN CN, Tagliamonte MS, Bassett M, Alam M, et al COVID-19 lineages in a minimally vaccinated island population: Genomic
epidemiology of SARS-CoV-2 in Haiti.
J Infect Dis. 2024 Oct 23:jiae520. doi: 10.1093. PubMedAbstract available
SANCHEZ-DE PRADA L, Garcia-Concejo A, Tamayo-Velasco A, Martin-Fernandez M, et al miRNome Profiling of Extracellular Vesicles in Patients With Severe COVID-19 and
Identification of Predictors of Mortality.
J Infect Dis. 2024;230:901-911. PubMedAbstract available
VERGOUWE M, Biemond JJ, van der Straten K, van Pul L, et al A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T-
and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2
Omicron-Infected Immunocompromised Individuals.
J Infect Dis. 2024;230:e860-e871. PubMedAbstract available
BROOKS KM, Baltrusaitis K, Clarke DF, Nachman S, et al Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With
COVID-19: Results From IMPAACT 2032.
J Infect Dis. 2024;230:878-888. PubMedAbstract available
FILES MA, Gentles L, Kehoe L, Adler A, et al Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in
Children.
J Infect Dis. 2024;230:889-900. PubMedAbstract available
DINIZ LM, Dias CS, Oliveira MCL, Simoes E Silva AC, et al Outcomes of SARS-CoV-2 and Seasonal Viruses Among 2 Million Adults Hospitalized
for Severe Acute Respiratory Infection During the COVID-19 Pandemic in Brazil.
J Infect Dis. 2024;230:868-877. PubMedAbstract available
AHTI J, Toivonen L, Ollila H, Ivaska L, et al Household Transmission and Clinical Features of Respiratory Tract Infections That
Were SARS-CoV-2 Positive and Negative.
J Infect Dis. 2024;230:e837-e846. PubMedAbstract available
CONNOR C, Taylor HA The Importance of Including Long COVID Outcomes When Developing Novel Treatments
for Acute COVID-19.
J Infect Dis. 2024;230:789-796. PubMedAbstract available
FRANCIS MR, Gidado S, Nuorti JP The Risk of SARS-CoV-2 Transmission in Community Indoor Settings: A Systematic
Review and Meta-analysis.
J Infect Dis. 2024;230:e824-e836. PubMedAbstract available
ALLEN DM, Reyne MI, Allingham P, Levickas A, et al Genomic Analysis and Surveillance of Respiratory Syncytial Virus Using
Wastewater-Based Epidemiology.
J Infect Dis. 2024;230:e895-e904. PubMedAbstract available
BABU TM, Jackson LA, El Sahly HM Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of
Administration.
J Infect Dis. 2024 Oct 16:jiae504. doi: 10.1093. PubMedAbstract available
DOBRZYNSKI D, Branche AR, Falsey AR Combination seasonal vaccines for influenza, RSV, SARS-CoV-2, and other
pathogens.
J Infect Dis. 2024 Oct 15:jiae507. doi: 10.1093. PubMed
HAGER DN, Zhu Y, Sohn I, Stubblefield WB, et al Effectiveness of the original monovalent mRNA COVID-19 vaccination series against
hospitalization for COVID-19-associated venous thromboembolism.
J Infect Dis. 2024 Oct 15:jiae502. doi: 10.1093. PubMedAbstract available
LU Y, Matuska K, McEvoy R, Izurieta HS, et al Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in
Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron
Period.
J Infect Dis. 2024 Oct 15:jiae503. doi: 10.1093. PubMedAbstract available
BUTT AA, Yan P, Abou-Samra AB, Shaikh OS, et al COVID-19 Disease Incidence and Severity in Previously Infected Unvaccinated
Compared with Previously Uninfected Vaccinated Persons.
J Infect Dis. 2024 Oct 8:jiae484. doi: 10.1093. PubMedAbstract available
September 2024
MURUGAIAH V, Watson SJ, Cunliffe RF, Temperton NJ, et al A transgenic mouse with a humanised B cell repertoire mounts an antibody response
to influenza infection and vaccination.
J Infect Dis. 2024 Sep 24:jiae472. doi: 10.1093. PubMedAbstract available
BOONYARATANAKORNKIT J, Wang Q, Nader A, Kimball L, et al The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the
Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant
Recipients.
J Infect Dis. 2024;230:670-679. PubMedAbstract available
NGUYEN HC, Lal KG, Balinsky CA, Hontz RD, et al Informing the Need for a SARS-CoV-2 Booster Based on the Immune Responses Among
Young Healthy Adults to Variants Circulating in Late 2023.
J Infect Dis. 2024;230:645-656. PubMedAbstract available
SINGH K, Rubenstein K, Callier V, Shaw-Saliba K, et al SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With
Severe Disease Outcomes That Improve in Response to Remdesivir.
J Infect Dis. 2024;230:624-634. PubMedAbstract available
KADOWAKI T, Sasaki A, Matsumoto N, Mitsuhashi T, et al Antibody Titers and the Risk of Infection During the SARS-CoV-2 Omicron Phase in
Bizen City, Japan.
J Infect Dis. 2024;230:662-669. PubMedAbstract available
NKOLOLA JP, Liu J, Collier AY, Jacob-Dolan C, et al High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
by Sensitive Nucleocapsid Assays.
J Infect Dis. 2024;230:e601-e604. PubMedAbstract available
GOLDING L, Watts AW, Shew J, Vineta Paramo M, et al A Novel Anti-nucleocapsid Antibody Avidity Method for Identifying SARS-CoV-2
Reinfections.
J Infect Dis. 2024;230:e579-e583. PubMedAbstract available
FISCHER RJ, Bushmaker T, Williamson BN, Perez-Perez L, et al Compartmentalized SARS-CoV-2 Replication in the Upper vs Lower Respiratory Tract
After Intranasal Inoculation or Aerosol Exposure.
J Infect Dis. 2024;230:657-661. PubMedAbstract available
LIN LY, Gantner P, Li S, Su B, et al Unpredicted protective function of Fc-mediated inhibitory antibodies for HIV and
SARS-CoV-2 vaccines.
J Infect Dis. 2024 Sep 20:jiae464. doi: 10.1093. PubMedAbstract available
WEBBY RJ, Uyeki TM An Update on Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.4.4b.
J Infect Dis. 2024 Sep 16:jiae379. doi: 10.1093. PubMedAbstract available
BAGDASARIAN N, Wineland N, Callo SL Personal Protective Equipment Guidance for Highly Pathogenic Avian Influenza H5N1
Should Be Adapted to Meet the Needs of Dairy Farm Workers.
J Infect Dis. 2024 Sep 16:jiae380. doi: 10.1093. PubMed
BAHAKEL H, Spieker AJ, Hayek H, Schuster JE, et al Immunogenicity and Reactogenicity of High-dose or Standard-dose Influenza Vaccine
in a Second Consecutive Influenza Season.
J Infect Dis. 2024 Sep 16:jiae454. doi: 10.1093. PubMedAbstract available
ONISIFOROU A, Zanos P From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links
Through Systems Bioinformatics.
J Infect Dis. 2024;230. PubMedAbstract available
TANG Y, Boribong BP, Swank ZN, Demokritou M, et al COVID-19 mRNA vaccines induce robust levels of IgG but limited amounts of IgA
within the oronasopharynx of young children.
J Infect Dis. 2024 Sep 10:jiae450. doi: 10.1093. PubMedAbstract available
JANES H, Fisher LH, Kee JJ, Parameswaran L, et al Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3
Trials.
J Infect Dis. 2024 Sep 3:jiae400. doi: 10.1093. PubMedAbstract available
August 2024
ZHANG C, Fang VJ, Chan KH, Leung GM, et al Interplay between viral shedding, age, and symptoms on individual infectiousness
of influenza cases in households.
J Infect Dis. 2024 Aug 28:jiae434. doi: 10.1093. PubMedAbstract available
LEOPOLD L, Vingerhoets J, Deleu S, Nalpas C, et al Efficacy and Safety of Pimodivir Combined with Standard-of-care in Hospitalized
and Non-hospitalized High-risk Adolescents and Adults with Influenza A Infection.
J Infect Dis. 2024 Aug 22:jiae408. doi: 10.1093. PubMedAbstract available
MEIER A, Sakoulas G, Nizet V, Ulloa ER, et al Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve
Infectious Disease Outcomes.
J Infect Dis. 2024;230:514-521. PubMedAbstract available
CHOUDHARY MC, Deo R, Evering TH, Chew KW, et al Characterization of Treatment Resistance and Viral Kinetics in the Setting of
Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute
Respiratory Syndrome Coronavirus 2.
J Infect Dis. 2024;230:394-402. PubMedAbstract available
BORDOY AE, Valles X, Fernandez-Nager J, Sanchez-Roig M, et al Analysis of a Large Severe Acute Respiratory Syndrome Coronavirus 2 (Alpha)
Outbreak in a Catalan Prison Using Conventional and Genomic Epidemiology.
J Infect Dis. 2024;230:374-381. PubMedAbstract available
KIM AE, Bennett JC, Luiten K, O'Hanlon JA, et al Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing
in a Community Setting.
J Infect Dis. 2024;230:363-373. PubMedAbstract available
STONE M, Spencer BR, Warden DE, Fink RV, et al Patient and Immunological Factors Associated With Delayed Clearance of Mucosal
Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence.
J Infect Dis. 2024;230:357-362. PubMedAbstract available
CORDERO DA JR Persons Deprived of Liberty in the Philippines: A Call to Health Equality.
J Infect Dis. 2024;230:522-523. PubMed
STRUNZ B, Maucourant C, Mehta A, Wan H, et al Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in
Severe COVID-19.
J Infect Dis. 2024;230:e318-e326. PubMedAbstract available
ROZNIK K, Andargie TE, Johnston TS, Gordon O, et al Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in
Children From Pediatric Severe Coronavirus Disease 2019.
J Infect Dis. 2024;230:e305-e317. PubMedAbstract available
POLLARD KJ, Traina-Dorge V, Medearis SM, Bosak A, et al Respiratory Syncytial Virus Infects Peripheral and Spinal Nerves and Induces
Chemokine-Mediated Neuropathy.
J Infect Dis. 2024;230:467-479. PubMedAbstract available
AVERIN A, Law A, Shea K, Atwood M, et al Episodic Cost of Lower Respiratory Tract Illness due to Respiratory Syncytial
Virus Among US Infants During the First Year of Life.
J Infect Dis. 2024;230:480-484. PubMedAbstract available
CARRICO J, Hicks KA, Wilson E, Panozzo CA, et al The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United
States.
J Infect Dis. 2024;230:e342-e352. PubMedAbstract available
GOH YS, Fong SW, Hor PX, Loh CY, et al Variant-Specific IgA Protects Against Omicron Infection.
J Infect Dis. 2024;230:e287-e291. PubMedAbstract available
MARCHESE AM, Rousculp M, Macbeth J, Beyhaghi H, et al The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower
Reactogenicity Than Messenger RNA: A Targeted Review.
J Infect Dis. 2024;230:e496-e502. PubMedAbstract available
EGESKOV-CAVLING AM, van Wijhe M, Yakimov V, Johannesen CK, et al Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus
Hospitalization in Young Children <5 Years of age.
J Infect Dis. 2024;230:e333-e341. PubMedAbstract available
LEWNARD JA, Hong V, Grant LR, Ackerson BK, et al Association of pneumococcal conjugate vaccination with SARS-CoV-2 infection among
older adult recipients of COVID-19 vaccines: a longitudinal cohort study.
J Infect Dis. 2024 Aug 5:jiae387. doi: 10.1093. PubMedAbstract available
July 2024
BEN MAMOUN C, Wormser GP Reply to Dow and Smith.
J Infect Dis. 2024;230:273. PubMed
WILLIAMS TC, Marlow R, Hardelid P, Lyttle MD, et al Clinical Impact of Serious Respiratory Disease in Children Under the Age of 2
Years During the 2021-2022 Bronchiolitis Season in England, Scotland, and
Ireland.
J Infect Dis. 2024;230:e111-e120. PubMedAbstract available
SIDHU JK, Siggins MK, Liew F, Russell CD, et al Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in
Fatal COVID-19.
J Infect Dis. 2024;230:e17-e29. PubMedAbstract available
HARTELOH P, van Mechelen R Mortality Rates of the Spanish Flu and Coronavirus Disease 2019 in the
Netherlands: A Historical Comparison.
J Infect Dis. 2024;230:38-44. PubMedAbstract available
LIM WW, Feng S, Wong SS, Sullivan SG, et al Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine
Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus
Infections.
J Infect Dis. 2024;230:152-160. PubMedAbstract available
TEHRANI ZR, Habibzadeh P, Flinko R, Chen H, et al Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow
After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2024;230:e30-e33. PubMedAbstract available
ZHENG X, Lu R, Pan D, Peng L, et al Regulatory T and CXCR3+ Circulating Tfh Cells Concordantly Shape the Neutralizing
Antibody Responses in Individuals Who Have Recovered from Mild COVID-19.
J Infect Dis. 2024;230:28-37. PubMedAbstract available
SCHWARZ TF, Hwang SJ, Ylisastigui P, Liu CS, et al Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory
Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial.
J Infect Dis. 2024;230:e102-e110. PubMedAbstract available
TENFORDE MW, Weber ZA, Yang DH, DeSilva MB, et al Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency
Department, Urgent Care, and Hospitalization Encounters Among US Adults,
2022-2023.
J Infect Dis. 2024;230:141-151. PubMedAbstract available
SUMNER KM, Yadav R, Noble EK, Sandford R, et al Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in
Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October
2021-June 2022.
J Infect Dis. 2024;230:45-54. PubMedAbstract available
LEDDEROSE C, Valsami EA, Elevado M, Junger WG, et al Adenosine Triphosphate Release From Influenza-Infected Lungs Enhances Neutrophil
Activation and Promotes Disease Progression.
J Infect Dis. 2024;230:120-130. PubMedAbstract available
FELL DB, Russell M, Fung SG, Swayze S, et al Effectiveness of Influenza Vaccination During Pregnancy Against
Laboratory-Confirmed Seasonal Influenza Among Infants Under 6 Months of Age in
Ontario, Canada.
J Infect Dis. 2024;230:e80-e92. PubMedAbstract available
BENNETT C, Rivers EJ, Woo W, Bloch M, et al Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2
Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial.
J Infect Dis. 2024;230:e4-e16. PubMedAbstract available
TERSTAPPEN J, Delemarre EM, Versnel A, White JT, et al RSV Neutralizing Antibodies in Dried Blood.
J Infect Dis. 2024;230:e93-e101. PubMedAbstract available
LEE K, Williams KV, Englund JA, Sullivan SG, et al The Potential Benefits of Delaying Seasonal Influenza Vaccine Selections for the
Northern Hemisphere: A Retrospective Modeling Study in the United States.
J Infect Dis. 2024;230:131-140. PubMedAbstract available
CHONG EA, Kumashie KG, Chong ER, Fabrizio J, et al Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and
Chronic Lymphocytic Leukemia.
J Infect Dis. 2024;230:15-27. PubMedAbstract available
LIN J, Bai S, He L, Yang Y, et al Cytotoxic Lymphocyte-Monocyte Complex Reflects the Dynamics of Coronavirus
Disease 2019 Systemic Immune Response.
J Infect Dis. 2024;230:5-14. PubMedAbstract available
BLOOM N, Ramirez SI, Cohn H, Parikh UM, et al SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human
memory B cell epitope recognition suggesting antibody feedback.
J Infect Dis. 2024 Jul 22:jiae371. doi: 10.1093. PubMedAbstract available
HILL-BATORSKI L, Weiner JA, Ackerman ME, Hatta Y, et al Intranasal M2SR (M2-deficient Single Replication) Influenza Vaccine Induces
Broadly Reactive Mucosal Antibody Production in Adults.
J Infect Dis. 2024 Jul 16:jiae361. doi: 10.1093. PubMedAbstract available
AGRAWAL P, Giron LB, Singh S, Haw NJ, et al Pre-pandemic Metabolic Correlates of COVID-19 Severity and Long COVID Incidence
in People Living with HIV.
J Infect Dis. 2024 Jul 16:jiae362. doi: 10.1093. PubMedAbstract available
CHIME N, Anspach B, Jain V, Laajalahti O, et al Phase 3 Study Assessing Lot-to-lot Consistency of RSVPreF3 Vaccine and its Immune
Response, Safety, and Reactogenicity When Co-administered with FLU-D-QIV.
J Infect Dis. 2024 Jul 5:jiae342. doi: 10.1093. PubMedAbstract available
MCCARRON M, Yau TS, Griffin C, Marcenac P, et al Do pregnant persons want influenza vaccines? Knowledge, attitudes, perceptions,
and practices toward influenza vaccines in 8 low- and middle-income countries.
J Infect Dis. 2024 Jul 2:jiae340. doi: 10.1093. PubMedAbstract available
June 2024
ANANWORANICH J, Lee IT, Ensz D, Carmona L, et al Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza
Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.
J Infect Dis. 2024 Jun 27:jiae329. doi: 10.1093. PubMedAbstract available
GOSWAMI J, Baqui AH, Doreski PA, Perez Marc G, et al Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
J Infect Dis. 2024 Jun 18:jiae316. doi: 10.1093. PubMedAbstract available
ATTUR M, Petrilli C, Adhikari S, Iturrate E, et al Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine
Release Syndrome and Mortality of COVID-19.
J Infect Dis. 2024;229:1740-1749. PubMedAbstract available
HARTELOH P, van Mechelen R Reply to Mattiuzzi and Lippi.
J Infect Dis. 2024;229:1930. PubMed
MATTIUZZI C, Lippi G Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus
Disease 2019 in Italy.
J Infect Dis. 2024;229:1928-1929. PubMed
GAY L, Rouviere MS, Mezouar S, Richaud M, et al Vgamma9Vdelta2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent
Effector Phenotypes in Patients With COVID-19.
J Infect Dis. 2024;229:1759-1769. PubMedAbstract available
IVERSEN KK, Ronit A, Ahlstrom MG, Nordestgaard BG, et al Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up.
J Infect Dis. 2024;229:1750-1758. PubMedAbstract available
LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant
Antibody Responses Compared to Natural Infection Alone.
J Infect Dis. 2024;229:1728-1739. PubMedAbstract available
LIM SY, Kim JW, Kim JY, Kang SW, et al The Association Between Antibody Responses and Prolonged Viable Severe Acute
Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A
Prospective Cohort Study.
J Infect Dis. 2024;229:1722-1727. PubMedAbstract available
AMSTUTZ A, Chammartin F, Audige A, Eichenberger AL, et al Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people
with compromised immune function (COVERALL-3).
J Infect Dis. 2024 Jun 7:jiae291. doi: 10.1093. PubMedAbstract available
May 2024
TOWNSEND L, Gillespie P, McGrath J, Kenny C, et al Health Care Personnel Workdays Lost and Direct Health Care Salary Costs Incurred
due to COVID-19 Infection in the Age of Widespread Vaccine Availability.
J Infect Dis. 2024 May 21:jiae223. doi: 10.1093. PubMedAbstract available
BEN MAMOUN C, Vydyam P Response to the Letter by Liu and Colleagues.
J Infect Dis. 2024;229:1601. PubMed
FOTOOH ABADI L, Sharma MB, Kelesidis T Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute
Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at
the Protein Level.
J Infect Dis. 2024;229:1382-1386. PubMedAbstract available
WONG M, Gain C, Sharma MB, Fotooh Abadi L, et al Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of
Lung Tissue Remodeling In Vitro and In Vivo.
J Infect Dis. 2024;229:1372-1381. PubMedAbstract available
DOS RAMOS ALMEIDA CJL, Veras FP, Paiva IM, Schneider AH, et al Neutrophil Virucidal Activity Against SARS-CoV-2 Is Mediated by Neutrophil
Extracellular Traps.
J Infect Dis. 2024;229:1352-1365. PubMedAbstract available
LEDUCQ V, Zafilaza K, Fauchois A, Ghidaoui E, et al Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus
Disease 2019 Treated by Monoclonal Antibodies.
J Infect Dis. 2024;229:1341-1351. PubMedAbstract available
MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al Hemagglutinin stalk-specific Fc-mediated functions are associated with protection
against influenza-illness after seasonal influenza vaccination in pregnant women.
J Infect Dis. 2024 May 14:jiae241. doi: 10.1093. PubMedAbstract available
SMITH CL, Didion E, Aung H, Tamilselvan B, et al Longitudinal analysis of nursing home residents' T cell responses after
SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2
infection history.
J Infect Dis. 2024 May 14:jiae234. doi: 10.1093. PubMedAbstract available
HOY G, Stadlbauer D, Balmaseda A, Kuan G, et al Humoral correlates of protection against influenza A H3N2 virus infection.
J Infect Dis. 2024 May 9:jiae258. doi: 10.1093. PubMedAbstract available
EBINGER JE, Sun N, Joung SY, Sanchez JMS, et al Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior
Infection or Vaccination.
J Infect Dis. 2024 May 8:jiae130. doi: 10.1093. PubMedAbstract available
April 2024
BI Q, Dickerman BA, Nguyen HQ, Martin ET, et al Reduced effectiveness of repeat influenza vaccination: distinguishing among
within-season waning, recent clinical infection, and subclinical infection.
J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093. PubMedAbstract available
JUHL AK, Lokso Dietz L, Schmeltz Sogaard O, Reekie J, et al Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following
vaccination and infection.
J Infect Dis. 2024 Apr 30:jiae215. doi: 10.1093. PubMedAbstract available
MORO RN, Mehaffy C, De P, Phillips E, et al Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing
Flu-like Reactions During Treatment of Latent Tuberculosis Infection.
J Infect Dis. 2024 Apr 19:jiae180. doi: 10.1093. PubMedAbstract available
ZAMA D, Zanaroli A, Corbelli A, Lo Vecchio A, et al SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive
Comprehensive Report of the Infectious Diseases Working Group of AIEOP.
J Infect Dis. 2024;229:1050-1058. PubMedAbstract available
GUILBAUD R, Franco Yusti AM, Leducq V, Zafilaza K, et al Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A
Retrospective Case-Control Study.
J Infect Dis. 2024;229:1041-1049. PubMedAbstract available
SIMOES EAF, Botteman M, Chirikov V Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory
Tract Infection in Japanese Children, 2011-2017.
J Infect Dis. 2024;229:1112-1122. PubMedAbstract available
WALSH EE, Falsey AR, Zareba AM, Jiang Q, et al Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and
Revaccination.
J Infect Dis. 2024 Apr 12:jiae185. doi: 10.1093. PubMedAbstract available
BARTSCH SM, O'Shea KJ, Weatherwax C, Strych U, et al What is the economic benefit of annual COVID-19 vaccination from the adult
individual perspective?
J Infect Dis. 2024 Apr 6:jiae179. doi: 10.1093. PubMedAbstract available
RECTO C, Fourati S, Khellaf M, Pawlotsky JM, et al Respiratory syncytial virus vs. Influenza virus infection: mortality and
morbidity comparison over 7 epidemic seasons in an elderly population.
J Infect Dis. 2024 Apr 4:jiae171. doi: 10.1093. PubMedAbstract available
March 2024
FIGUEROA AL, Azzi JR, Eghtesad B, Priddy F, et al Safety and Immunogenicity of the mRNA-1273 COVID-19 Vaccine in Solid Organ
Transplant Recipients.
J Infect Dis. 2024 Mar 21:jiae140. doi: 10.1093. PubMedAbstract available
FINSTERER J Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are
Unsuitable for Assessing Post-COVID Cognitive Impairment.
J Infect Dis. 2024;229:918-919. PubMed
ROSSLER A, Knabl L, Netzl A, Bante D, et al Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus
Disease 2019 Vaccine Booster.
J Infect Dis. 2024;229:644-647. PubMedAbstract available
LI X, Zhou G, Sun X, Qu S, et al NLRP12 Senses the SARS-CoV-2 Membrane Protein and Promotes an Inflammatory
Response.
J Infect Dis. 2024;229:660-670. PubMedAbstract available
JENSEN TO, Grandits GA, Jain MK, Murray TA, et al Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of
Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
J Infect Dis. 2024;229:671-679. PubMedAbstract available
BAY P, Loegel C, Ly A, Soulier A, et al Clinical Phenotypes and Molecular Characteristics of Respiratory Syncytial Virus
in Adults: A Monocentric Prospective Study Between 2019 and 2022.
J Infect Dis. 2024;229:728-732. PubMedAbstract available
ALI YM, Carnell GW, Fumagalli S, Mercurio D, et al Inhibition of the Lectin Pathway of Complement Activation Reduces Acute
Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.
J Infect Dis. 2024;229:680-690. PubMedAbstract available
SCOTT N, Martinovich KM, Granland CM, Seppanen EJ, et al Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity,
and Prevents Development of Otitis Media in Mice.
J Infect Dis. 2024 Mar 12:jiae069. doi: 10.1093. PubMedAbstract available
SEPULVEDA-PACHON IT, Dunne EM, Hanquet G, Baay M, et al Effect of pneumococcal conjugate vaccines on viral respiratory infections: a
systematic literature review.
J Infect Dis. 2024 Mar 11:jiae125. doi: 10.1093. PubMedAbstract available
LIM WW, Shuo F, Wong SS, Sullivan SG, et al Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy
against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093. PubMedAbstract available
HAK SF, Venekamp RP, Billard MN, van Houten MA, et al Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term
Infants: An International Prospective Birth Cohort Study.
J Infect Dis. 2024;229. PubMedAbstract available
JOHNSON M, Chelysheva I, Oner D, McGinley J, et al A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity
in Infants.
J Infect Dis. 2024;229. PubMedAbstract available
OSEI-YEBOAH R, Johannesen CK, Egeskov-Cavling AM, Chen J, et al Respiratory Syncytial Virus-Associated Hospitalization in Adults With
Comorbidities in 2 European Countries: A Modeling Study.
J Infect Dis. 2024;229. PubMedAbstract available
CHAPPIN K, Besteman SB, Hennus MP, Wildenbeest JG, et al Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype
in Infants With Severe Respiratory Syncytial Virus Infection.
J Infect Dis. 2024;229. PubMedAbstract available
VAN ROEKEL C, Poukka E, Turunen T, Nohynek H, et al Effectiveness of Immunization Products Against Medically Attended Respiratory
Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control
Study.
J Infect Dis. 2024;229. PubMedAbstract available
KENMOE S, Chu HY, Dawood FS, Milucky J, et al Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections
During Pregnancy.
J Infect Dis. 2024;229. PubMedAbstract available
OSEI-YEBOAH R, Zhu F, Wang X, Nair H, et al Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels
Among Children and Adults in Scotland.
J Infect Dis. 2024;229. PubMedAbstract available
SHEIKH Z, Potter E, Li Y, Cohen RA, et al Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A
Systematic Review.
J Infect Dis. 2024;229. PubMedAbstract available
EGESKOV-CAVLING AM, Johannesen CK, Lindegaard B, Fischer TK, et al Underreporting and Misclassification of Respiratory Syncytial Virus-Coded
Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.
J Infect Dis. 2024;229. PubMedAbstract available
ASLANIKASHVILI A, Rylander C, Manjavidze T, Gamkrelidze A, et al Relationship between hepatitis C infection and treatment status and
COVID-19-related hospitalizations in Georgia.
J Infect Dis. 2024 Mar 1:jiae103. doi: 10.1093. PubMedAbstract available
February 2024
SHAW CA, Essink B, Harper C, Mithani R, et al Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month
Booster in a Phase I Clinical Trial in Healthy Older Adults.
J Infect Dis. 2024 Feb 22:jiae081. doi: 10.1093. PubMedAbstract available
CASADEVALL A, Sullivan DJ Late Administration and Corticosteroid Usage Explain Inefficacy in COVID-19
Convalescent Plasma Trial.
J Infect Dis. 2024;229:617-618. PubMed
KANBERG N, Grahn A, Stentoft E, Bremell D, et al COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker
Abnormalities in Patients With Neurocognitive Post-COVID Complications.
J Infect Dis. 2024;229:493-501. PubMedAbstract available
YOUNG BR, Ho F, Lin Y, Lau EHY, et al Estimation of the Time-Varying Effective Reproductive Number of COVID-19 Based on
Multivariate Time Series of Severe Health Outcomes.
J Infect Dis. 2024;229:502-506. PubMedAbstract available
VUJKOVIC A, Ha M, de Block T, van Petersen L, et al Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+
T Cells.
J Infect Dis. 2024;229:507-516. PubMedAbstract available
MONROE JM, Quach HQ, Punia S, Enninga EAL, et al Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in
Pregnancy.
J Infect Dis. 2024;229:473-484. PubMedAbstract available
HEIMONEN J, Chow EJ, Wang Y, Hughes JP, et al Risk of Subsequent Respiratory Virus Detection After Primary Virus Detection in a
Community Household Study-King County, Washington, 2019-2021.
J Infect Dis. 2024;229:422-431. PubMedAbstract available
MAKHSOUS N, Goya S, Avendano CC, Rupp J, et al Within-Host Rhinovirus Evolution in Upper and Lower Respiratory Tract Highlights
Capsid Variability and Mutation-Independent Compartmentalization.
J Infect Dis. 2024;229:403-412. PubMedAbstract available
AMINISANI N, Wood T, Jelley L, Wong C, et al The burden of HMPV and influenza associated hospitalizations in adults in New
Zealand, 2012-2015.
J Infect Dis. 2024 Feb 13:jiae064. doi: 10.1093. PubMedAbstract available
CHALKIAS S, McGhee N, Whatley JL, Essink B, et al Interim report of the reactogenicity and immunogenicity of SARS-CoV-2
XBB-containing vaccines.
J Infect Dis. 2024 Feb 13:jiae067. doi: 10.1093. PubMedAbstract available
MUNOZ-QUILES C, Lopez-Lacort M, Urchueguia A, Diez-Domingo J, et al Risk of cardiovascular events after influenza: A population-based Self Controlled
Case Series study, Spain 2011-2018.
J Infect Dis. 2024 Feb 8:jiae070. doi: 10.1093. PubMedAbstract available
January 2024
SHAW CA, Mithani R, Kapoor A, Dhar R, et al Safety, Tolerability and Immunogenicity of a mRNA-based RSV Vaccine in Healthy
Young Adults in a Phase 1 Clinical Trial.
J Infect Dis. 2024 Jan 31:jiae035. doi: 10.1093. PubMedAbstract available
LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant
antibody responses compared to natural infection or vaccination alone.
J Infect Dis. 2024 Jan 29:jiae046. doi: 10.1093. PubMed
ABELA IA, Hauser A, Schwarzmuller M, Pasin C, et al Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss
HIV Cohort Study.
J Infect Dis. 2024 Jan 16:jiae002. doi: 10.1093. PubMedAbstract available
HEDBERG P, Naucler P Post-COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs
the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden.
J Infect Dis. 2024;229:133-136. PubMedAbstract available
WEI SC, Freeman D, Himschoot A, Clarke KEN, et al Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health
Outcomes During Alpha- and Delta-Variant Predominant Periods: September
2020-November 2021.
J Infect Dis. 2024;229:122-132. PubMedAbstract available
SULLIVAN T Lessons (Machine) Learned From COVID-19.
J Infect Dis. 2024;229:7-9. PubMedAbstract available
CARROLL TD, Wong T, Morris MK, Di Germanio C, et al Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of
Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
J Infect Dis. 2024 Jan 12:jiad568. doi: 10.1093. PubMedAbstract available
HOWARD LM, Jensen TL, Goll JB, Gelber CE, et al Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine
Recipients.
J Infect Dis. 2024 Jan 5:jiad611. doi: 10.1093. PubMedAbstract available
December 2023
SAJKOV D, Woodman R, Honda-Okubo Y, Barbara J, et al A Multi-Season Randomised Controlled Trial of Advax-Adjuvanted Seasonal Influenza
Vaccine in Participants with Chronic Disease or Older Age.
J Infect Dis. 2023 Dec 29:jiad589. doi: 10.1093. PubMedAbstract available
ZHANG Y, Zhou Y, Chen J, Wu J, et al Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2
Breakthrough Infection.
J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093. PubMedAbstract available
WIDAGDO W, Bastian AR, Jastorff AM, Scheys I, et al Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and
High-dose Influenza Vaccine in Adults 65 Years and Older: a Noninferiority Trial.
J Infect Dis. 2023 Dec 22:jiad594. doi: 10.1093. PubMedAbstract available
HERMIDA N, Ferguson M, Leroux-Roels I, Pagnussat S, et al Safety and Immunogenicity of Respiratory Syncytial Virus Pre-fusion Maternal
Vaccine Co-administered with Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2
Study.
J Infect Dis. 2023 Dec 22:jiad560. doi: 10.1093. PubMedAbstract available
YAMAMOTO S, Matsuda K, Maeda K, Horii K, et al Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and
Long COVID: A Propensity Score-Matched Analysis.
J Infect Dis. 2023;228:1652-1661. PubMedAbstract available
PENETRA SLS, Santos HFP, Resende PC, Bastos LS, et al SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de
Janeiro.
J Infect Dis. 2023;228:1680-1689. PubMedAbstract available
CHENE A, Desrames A, Tomlinson A, Ruffie C, et al An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous
Anti-Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike.
J Infect Dis. 2023;228:1675-1679. PubMedAbstract available
HUH K, Kang M, Kim YE, Choi Y, et al Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid
Organ Transplant Recipients.
J Infect Dis. 2023 Dec 14:jiad501. doi: 10.1093. PubMedAbstract available
WEST AC, Harpur CM, Le Page MA, Lam M, et al Harnessing endogenous peptide compounds as potential therapeutics for severe
influenza.
J Infect Dis. 2023 Dec 7:jiad566. doi: 10.1093. PubMedAbstract available
TENFORDE MW, Weber ZA, Yang DH, DeSilva MB, et al Influenza vaccine effectiveness against influenza-A-associated emergency
department, urgent care, and hospitalization encounters among U.S. adults,
2022-2023.
J Infect Dis. 2023 Dec 2:jiad542. doi: 10.1093. PubMedAbstract available
November 2023
TUTTLE DJ, Castanha PMS, Nasser A, Wilkins MS, et al SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased
viremia and Nef antibodies in men with HIV-1.
J Infect Dis. 2023 Nov 30:jiad544. doi: 10.1093. PubMedAbstract available
FELL DB, Russell M, Fung SG, Swayze S, et al Effectiveness of maternal influenza vaccination during pregnancy against
laboratory-confirmed seasonal influenza among infants under 6 months of age in
Ontario, Canada.
J Infect Dis. 2023 Nov 29:jiad539. doi: 10.1093. PubMedAbstract available
LEE K, Williams KV, Englund JA, Sullivan SG, et al The potential benefits of delaying seasonal influenza vaccine selections for the
Northern Hemisphere: a retrospective modeling study in the United States.
J Infect Dis. 2023 Nov 29:jiad541. doi: 10.1093. PubMedAbstract available
KARABA AH, Morgenlander WR, Johnston TS, Hage C, et al Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant
Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
J Infect Dis. 2023 Nov 29:jiad534. doi: 10.1093. PubMedAbstract available
FRANKLIN A, John TM, Khawaja F, Jiang Y, et al Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in
Patients With Cancer.
J Infect Dis. 2023;228:1549-1558. PubMedAbstract available
ERNST T, Ryan MC, Liang HJ, Wang JP, et al Neuronal and Glial Metabolite Abnormalities in Participants With Persistent
Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance
Spectroscopy Study.
J Infect Dis. 2023;228:1559-1570. PubMedAbstract available
ONWUCHEKWA C, Atwell J, Moreo LM, Menon S, et al Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A
Systematic Review and Meta-analysis.
J Infect Dis. 2023;228:1516-1527. PubMedAbstract available
OSEI-YEBOAH R, Spreeuwenberg P, Del Riccio M, Fischer TK, et al Estimation of the Number of Respiratory Syncytial Virus-Associated
Hospitalizations in Adults in the European Union.
J Infect Dis. 2023;228:1539-1548. PubMedAbstract available
DEL RICCIO M, Spreeuwenberg P, Osei-Yeboah R, Johannesen CK, et al Burden of Respiratory Syncytial Virus in the European Union: estimation of
RSV-associated hospitalizations in children under 5 years.
J Infect Dis. 2023;228:1528-1538. PubMedAbstract available
LU X, Liu F, Tzeng WP, York IA, et al Antibody-mediated Suppression Regulates the Humoral Immune Response to Influenza
Vaccination in Humans.
J Infect Dis. 2023 Nov 20:jiad493. doi: 10.1093. PubMedAbstract available
JI W, Guthmiller J Goldilocks zone of preexisting immunity: too little or too much suppresses
diverse antibody responses against influenza viruses.
J Infect Dis. 2023 Nov 18:jiad494. doi: 10.1093. PubMedAbstract available
HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19
mRNA vaccine dose among immunocompromised individuals.
J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093. PubMedAbstract available
MORI M, Doi T, Murata M, Moriyama Y, et al Impact of nutritional status on antibody titer after booster mRNA COVID-19
vaccine among elderly adults in Japan.
J Infect Dis. 2023 Nov 14:jiad495. doi: 10.1093. PubMedAbstract available
LASRADO N, Barouch DH SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds.
J Infect Dis. 2023;228:1311-1313. PubMedAbstract available
LOWENSTEYN YN, Zheng Z, Rave N, Bannier MAGE, et al Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following
the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study.
J Infect Dis. 2023;228:1394-1399. PubMedAbstract available
JITTAMALA P, Schilling WHK, Watson JA, Luvira V, et al Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An
Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
J Infect Dis. 2023;228:1318-1325. PubMedAbstract available
KYO M, Zhu Z, Shibata R, Fujiogi M, et al Respiratory Virus-Specific Nasopharyngeal Lipidome Signatures and Severity in
Infants With Bronchiolitis: A Prospective Multicenter Study.
J Infect Dis. 2023;228:1410-1420. PubMedAbstract available
NAKAJO K, Nishiura H Age-Dependent Risk of Respiratory Syncytial Virus Infection: A Systematic Review
and Hazard Modeling From Serological Data.
J Infect Dis. 2023;228:1400-1409. PubMedAbstract available
ZHONG S, Ng TWY, Skowronski DM, Iuliano AD, et al Standard-dose versus MF59-adjuvanted, high-dose or recombinant-hemagglutinin
influenza vaccine immunogenicity in older adults: comparison of A(H3N2) antibody
response by prior season's vaccine status.
J Infect Dis. 2023 Nov 10:jiad497. doi: 10.1093. PubMedAbstract available
HEDSKOG C, Rodriguez L, Roychoudhury P, Huang ML, et al Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment
Trial-1 (ACTT-1).
J Infect Dis. 2023;228:1263-1273. PubMedAbstract available
WONG JY, Cheung JK, Lin Y, Bond HS, et al Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With
the Ancestral Strain and Omicron BA.2 Variant in Hong Kong.
J Infect Dis. 2023;228:1231-1239. PubMedAbstract available
EVANS MV, Ramiadantsoa T, Kauffman K, Moody J, et al Sociodemographic Variables Can Guide Prioritized Testing Strategies for Epidemic
Control in Resource-Limited Contexts.
J Infect Dis. 2023;228:1189-1197. PubMedAbstract available
October 2023
RUDOLPH AE, Khan FL, Shah A, Singh TG, et al Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against symptomatic
COVID-19 among immunocompetent individuals testing at a large US retail pharmacy.
J Infect Dis. 2023 Oct 31:jiad474. doi: 10.1093. PubMedAbstract available
ASAMOAH-BOAHENG M, Grunau B, Karim ME, Kirkham TL, et al The association of post-COVID-related symptoms and preceding SARS-CoV-2 infection
among fully vaccinated paramedics in Canada.
J Infect Dis. 2023 Oct 31:jiad475. doi: 10.1093. PubMedAbstract available
TURCINOVIC J, Kuhfeldt K, Sullivan M, Landaverde L, et al Transmission Dynamics and Rare Clustered Transmission Within an Urban University
Population Before Widespread Vaccination.
J Infect Dis. 2023 Oct 19:jiad397. doi: 10.1093. PubMedAbstract available
ANDINO R, Kirkegaard K, Macadam A, Racaniello VR, et al The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and
Prototype Pathogens.
J Infect Dis. 2023;228. PubMedAbstract available
MORABITO KM, Cassetti MC, DeRocco AJ, Deschamps AM, et al Viral Prototypes for Pandemic Preparedness: The Road Ahead.
J Infect Dis. 2023;228. PubMedAbstract available
DALMAT RR, Hao L, Prabhu R, Rechkina E, et al Rapid Antigen and Antibody Microfluidic Immunofluorescence Assays Compared to
Culture, PCR, and Laboratory Reference Tests: Performance in a Longitudinal
Cohort.
J Infect Dis. 2023;228:1066-1070. PubMedAbstract available
TUFFY KM, Ahani B, Aksyuk AA, Avila M, et al Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not
Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants.
J Infect Dis. 2023;228:1055-1059. PubMedAbstract available
BUTT AA, Yan P, Shaikh OS, Omer SB, et al Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected
Nonhospitalized High-risk Population With COVID-19.
J Infect Dis. 2023;228:1033-1041. PubMedAbstract available
ADHIKARI EH, Lu P, Kang YJ, McDonald AR, et al Diverging maternal and cord antibody functions from SARS-CoV-2 infection and
vaccination in pregnancy.
J Infect Dis. 2023 Oct 10:jiad421. doi: 10.1093. PubMedAbstract available
LEDDEROSE C, Valsami EA, Elevado M, Junger WG, et al ATP release from influenza-infected lungs enhances neutrophil activation and
promotes disease progression.
J Infect Dis. 2023 Oct 6:jiad442. doi: 10.1093. PubMedAbstract available
HSU FC, Pan LC, Huang YF, Yang CH, et al A Dynamic Model for Estimating the Retention Duration of Neutralizing Antibody
Titers after Vaccination in a COVID-19 Convalescent Population.
J Infect Dis. 2023 Oct 5:jiad431. doi: 10.1093. PubMedAbstract available
GREWAL R, Buchan SA, Nguyen L, Nasreen S, et al Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses
against Omicron severe outcomes among adults aged >/=50 years in Ontario, Canada: a
Canadian Immunization Research Network (CIRN) Study.
J Infect Dis. 2023 Oct 5:jiad419. doi: 10.1093. PubMedAbstract available
CHU WT, Reza SMS, Anibal JT, Landa A, et al Artificial Intelligence and Infectious Disease Imaging.
J Infect Dis. 2023;228. PubMedAbstract available
HAMMOUD DA, Clifford Lane H, Jain SK Molecular Imaging of Infections: Advancing the Search for the Hidden Enemy.
J Infect Dis. 2023;228. PubMedAbstract available
LEE E, Bates B, Kuhrt N, Andersen KM, et al National Trends in Anticoagulation Therapy for COVID-19 Hospitalized Adults in
the United States: Analyses of the National COVID Cohort Collaborative.
J Infect Dis. 2023;228:895-906. PubMedAbstract available
YUNOKI M, Kubota-Koketsu R, Imada T, Furuyama K, et al Changes in Anti-SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors
in Japan: A Potential Tool for Mass-Immunity Evaluation.
J Infect Dis. 2023;228:889-894. PubMedAbstract available
SKARBINSKI J, Nugent JR, Wood MS, Liu L, et al Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Genomic Variation
Associated With Breakthrough Infection in Northern California: A Retrospective
Cohort Study.
J Infect Dis. 2023;228:878-888. PubMedAbstract available
MUNOZ-QUILES C, Lopez-Lacort M, Diez-Domingo J, Orrico-Sanchez A, et al Bronchiolitis, Regardless of Its Etiology and Severity, Is Associated With
Increased Risk of Asthma: A Population-Based Study.
J Infect Dis. 2023;228:840-850. PubMedAbstract available
September 2023
MADSEN AMR, Schaltz-Buchholzer F, Nielsen S, Benfield T, et al Using BCG vaccine to enhance non-specific protection of health care workers
during the COVID-19 pandemic: a randomized controlled trial.
J Infect Dis. 2023 Sep 29:jiad422. doi: 10.1093. PubMedAbstract available
ANDREEV K, Jones JC, Seiler P, Kandeil A, et al Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses
Circulating Globally in 2022-2023.
J Infect Dis. 2023 Sep 28:jiad418. doi: 10.1093. PubMedAbstract available
HOWA AC, Zhu Y, Wyatt D, Markus T, et al Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using
Capture-Recapture.
J Infect Dis. 2023 Sep 28:jiad417. doi: 10.1093. PubMedAbstract available
HAYDEN FG, Lenk RP, Epstein C, Kang LL, et al Oral Favipiravir Exposure and Pharmacodynamic Effects in Outpatient Adults with
Acute Influenza.
J Infect Dis. 2023 Sep 22:jiad409. doi: 10.1093. PubMedAbstract available
BASU THAKUR P, Mrotz VJ, Maines TR, Belser JA, et al Ferrets as a mammalian model to study influenza virus-bacteria interactions.
J Infect Dis. 2023 Sep 22:jiad408. doi: 10.1093. PubMedAbstract available
CHEEMARLA NR, Watkins TA, Mihaylova VT, Foxman EF, et al Viral interference during influenza A-SARS-CoV-2 coinfection of the human airway
epithelium and reversal by oseltamivir.
J Infect Dis. 2023 Sep 18:jiad402. doi: 10.1093. PubMedAbstract available
REBELO M, Tang C, Coelho AR, Labao-Almeida C, et al De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From
Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis. 2023;228:723-733. PubMedAbstract available
BUTT AA, Yan P, Shaikh OS, Talisa VB, et al Nirmatrelvir/ritonavir Use and Hospitalizations or Death in Previously Uninfected
Non-hospitalized High-risk Population with COVID-19: A matched cohort study.
J Infect Dis. 2023 Sep 15:jiad393. doi: 10.1093. PubMedAbstract available
LEROUX-ROELS I, Van Ranst M, Vandermeulen C, Abeele CV, et al Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus
Prefusion F Vaccine in Older Adults: A Phase 2b Study.
J Infect Dis. 2023 Sep 12:jiad321. doi: 10.1093. PubMedAbstract available
FROBERG J, Koomen VJCH, van der Gaast-de Jongh CE, Philipsen R, et al Primary exposure to SARS-CoV-2 via infection or vaccination determines mucosal
antibody-dependent ACE2 binding inhibition.
J Infect Dis. 2023 Sep 7:jiad385. doi: 10.1093. PubMedAbstract available
MARTIN JM, Moehling Geffel K, Ortiz MA, Rajasundaram D, et al Differential Induction of Interferon Stimulated Genes by Cell-based Versus
Egg-based Quadrivalent Influenza Vaccines in Children During the 2018-19 Season.
J Infect Dis. 2023 Sep 4:jiad380. doi: 10.1093. PubMedAbstract available
August 2023
CHEW KW, Moser C, Yeh E, Wohl DA, et al Validity and Characterization of Time to Symptom Resolution Outcome Measures in
the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis. 2023;228. PubMedAbstract available
EVERING TH, Moser CB, Jilg N, Yeh E, et al Long COVID After Bamlanivimab Treatment.
J Infect Dis. 2023;228. PubMedAbstract available
MOSER CB, Chew KW, Giganti MJ, Li JZ, et al Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay
Limit of Quantification in COVID-19 Clinical Trials.
J Infect Dis. 2023;228. PubMedAbstract available
MOSER CB, Chew KW, Ritz J, Newell M, et al Pooling Different Placebos as a Control Group in a Randomized Platform Trial:
Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
J Infect Dis. 2023;228. PubMedAbstract available
RIBEIRO RM, Choudhary MC, Deo R, Giganti MJ, et al Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis. 2023;228. PubMedAbstract available
LI Y, Moser C, Aga E, Currier JS, et al Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis. 2023;228. PubMedAbstract available
CURRIER JS, Moser C, Eron JJ, Chew KW, et al ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the
Treatment of Early COVID-19 in Outpatients.
J Infect Dis. 2023;228. PubMedAbstract available
GIGANTI MJ, Chew KW, Eron JJ, Li JZ, et al Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and
Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate
COVID-19.
J Infect Dis. 2023;228. PubMedAbstract available
WAYHAM NP, Niedecken AR, Simons JF, Chiang YY, et al A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
J Infect Dis. 2023;228:555-563. PubMedAbstract available
SUNG MH, Billings W, Carlock MA, Hanley HB, et al Assessment of humoral immune responses to repeated influenza vaccination in a
multiyear cohort: a five-year follow-up.
J Infect Dis. 2023 Aug 25:jiad319. doi: 10.1093. PubMedAbstract available
SARIOL A, Vickers MA, Christensen SM, Weiskopf D, et al Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune
response in diabetic and control pediatric patients.
J Infect Dis. 2023 Aug 25:jiad366. doi: 10.1093. PubMedAbstract available
SUN X, Belser JA, Pulit-Penaloza JA, Brock N, et al Pathogenesis and transmission assessment of three swine-origin influenza A(H3N2)
viruses with zoonotic risk to humans isolated in the U.S from 2017-2020.
J Infect Dis. 2023 Aug 21:jiad359. doi: 10.1093. PubMedAbstract available
MERENSTEIN C, Fitzgerald AS, Khatib LA, Graham-Wooten J, et al Effects of Mask Reuse on the Oropharyngeal, Skin, and Mask Microbiome.
J Infect Dis. 2023;228:479-486. PubMedAbstract available
YOUNG BR, Yang B, Wu P, Adam DC, et al Residential Clustering of Coronavirus Disease 2019 Cases and Efficiency of
Building-Wide Compulsory Testing Notices as a Transmission Control Measure in
Hong Kong.
J Infect Dis. 2023;228:426-430. PubMedAbstract available
FAUCI AS, Folkers GK Pandemic Preparedness and Response: Lessons From COVID-19.
J Infect Dis. 2023;228:422-425. PubMedAbstract available
ROWLEY AH, Arrollo D, Shulman ST, Torres A, et al Analysis of Plasmablasts From Children With Kawasaki Disease Reveals Evidence of
a Convergent Antibody Response to a Specific Protein Epitope.
J Infect Dis. 2023;228:412-421. PubMedAbstract available
DUARTE LF, Vazquez Y, Diethelm-Varela B, Pavez V, et al Differential Sars-Cov-2-Specific Humoral Response in Inactivated
Virus-Vaccinated, Convalescent, and Breakthrough Subjects.
J Infect Dis. 2023 Aug 12:jiad320. doi: 10.1093. PubMedAbstract available
ZAVALIS EA, Contopoulos-Ioannidis DG, Ioannidis JPA Transparency in Infectious Disease Research: Meta-research Survey of Specialty
Journals.
J Infect Dis. 2023;228:227-234. PubMedAbstract available
ANDEREGG N, Schwab T, Borcard L, Mugglin C, et al Population-Based Severe Acute Respiratory Syndrome Coronavirus 2 Whole-Genome
Sequencing and Contact Tracing During the Coronavirus Disease 2019 Pandemic in
Switzerland.
J Infect Dis. 2023;228:251-260. PubMedAbstract available
DIMCHEFF DE, Blair CN, Zhu Y, Chappell JD, et al Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha,
Delta, and Omicron Variants.
J Infect Dis. 2023;228:235-244. PubMedAbstract available
PARASKEVIS D, Gkova M, Mellou K, Gerolymatos G, et al Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir as treatments
for COVID-19 in high-risk patients.
J Infect Dis. 2023 Aug 11:jiad324. doi: 10.1093. PubMedAbstract available
WANG FZ, Zhang CH, Tang L, Rodewald LE, et al An observational prospective cohort study of vaccine effectiveness against
SARS-CoV-2 infection of an aerosolized, inhaled adenovirus-type-5-vectored
COVID-19 vaccine given as a second booster dose in Guangzhou city, China.
J Infect Dis. 2023 Aug 11:jiad338. doi: 10.1093. PubMedAbstract available
NOBLE CC, Messina NL, Pittet LF, Curtis N, et al Interpreting the results of trials of BCG vaccination for protection against
COVID-19.
J Infect Dis. 2023 Aug 10:jiad316. doi: 10.1093. PubMedAbstract available
YOON JG, Kim YE, Choi MJ, Choi WS, et al Herpes zoster reactivation after mRNA and adenovirus-vectored coronavirus disease
2019 vaccination: Analysis of National Health Insurance Database.
J Infect Dis. 2023 Aug 7:jiad297. doi: 10.1093. PubMedAbstract available
HALL VG, Teh BW COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T
Therapy: Immune Response, Real-World Effectiveness, and Implications for the
Future.
J Infect Dis. 2023;228. PubMedAbstract available
ANTINORI A, Bausch-Jurken M The Burden of COVID-19 in the Immunocompromised Patient: Implications for
Vaccination and Needs for the Future.
J Infect Dis. 2023;228. PubMedAbstract available
BONANNI P, Ceddia F, Dawson R A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination
in Immunocompromised Populations.
J Infect Dis. 2023;228. PubMedAbstract available
SUBRAMANIAN V Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19
Vaccination Among Recipients of Solid Organ Transplants.
J Infect Dis. 2023;228. PubMedAbstract available
ROUPHAEL N, Bausch-Jurken M COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement
Therapy: Immune Response, Real-World Effectiveness, and Implications for the
Future.
J Infect Dis. 2023;228. PubMedAbstract available
WILLICOMBE M Foreword: Preventing COVID-19 Among the Immunocompromised Population.
J Infect Dis. 2023;228. PubMedAbstract available
PARIS R SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With
Primary Immunodeficiencies.
J Infect Dis. 2023;228. PubMedAbstract available
FINCKH A, Ciurea A, Raptis CE, Rubbert-Roth A, et al Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients
With Immune-Mediated Inflammatory Diseases.
J Infect Dis. 2023;228. PubMedAbstract available
LIU J, Cao F, Luo C, Guo Y, et al Stroke Following COVID-19 Vaccination: Evidence Based on Different Designs of
Real-World Studies.
J Infect Dis. 2023 Aug 3:jiad306. doi: 10.1093. PubMedAbstract available
BRAUNSTEIN SL, Wahnich A, Lazar R COVID-19 outcomes among people with HIV and COVID-19 in New York City.
J Infect Dis. 2023 Aug 3:jiad311. doi: 10.1093. PubMedAbstract available
COHEN LE, Hansen CL, Andrew MK, McNeil SA, et al Predictors of severity of influenza-related hospitalizations: Results from the
Global Influenza Hospital Surveillance Network (GIHSN).
J Infect Dis. 2023 Aug 1:jiad303. doi: 10.1093. PubMedAbstract available
July 2023
KARRON RA, Luongo C, Woods S, Oliva J, et al Evaluation of the live-attenuated intranasal respiratory syncytial virus (RSV)
vaccine RSV/6120/DeltaNS2/1030s in RSV-seronegative young children.
J Infect Dis. 2023 Jul 26:jiad281. doi: 10.1093. PubMedAbstract available
SAEZ-LLORENS X, Norero X, Mussi-Pinhata MM, Luciani K, et al Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus
vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.
J Infect Dis. 2023 Jul 21:jiad271. doi: 10.1093. PubMedAbstract available
EL SAHLY HM, Yildirim I, Frey SE, Winokur P, et al Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9)
Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.
J Infect Dis. 2023 Jul 19:jiad276. doi: 10.1093. PubMedAbstract available
JAGER M, Diem G, Sahanic S, Fux V, et al Immunity of Heterologously and Homologously Boosted or Convalescent Individuals
Against Omicron BA.1, BA.2, and BA.4/5 Variants.
J Infect Dis. 2023;228:160-168. PubMedAbstract available
TAIWO BO, Chew KW, Moser C, Wohl DA, et al Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody
Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis. 2023;228:133-142. PubMedAbstract available
ONWUCHEKWA C, Moreo LM, Menon S, Machado B, et al Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to
Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis.
J Infect Dis. 2023;228:173-184. PubMedAbstract available
ROA CC, de Los Reyes MRA, Plennevaux E, Smolenov I, et al Superior boosting of neutralizing titers against Omicron SARS-CoV-2 variants by
heterologous SCB-2019 vaccine vs a homologous booster in CoronaVac-primed adults.
J Infect Dis. 2023 Jul 13:jiad262. doi: 10.1093. PubMedAbstract available
COMEAUX CA, Bart S, Bastian AR, Klyashtornyy V, et al Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-based Vaccine
Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
J Infect Dis. 2023 Jul 11:jiad220. doi: 10.1093. PubMedAbstract available
FERNANDEZ-GONZALEZ M, Agullo V, Garcia JA, Padilla S, et al T-cell immunity against SARS-CoV-2 measured by an interferon-gamma release assay is
strongly associated with patient outcomes in vaccinated persons hospitalized with
Delta or Omicron variants.
J Infect Dis. 2023 Jul 7:jiad260. doi: 10.1093. PubMedAbstract available
June 2023
SRINIVASA VR, Griffith MP, Waggle KD, Johnson M, et al Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2
Transmission Among University Students in Western Pennsylvania.
J Infect Dis. 2023;228:37-45. PubMedAbstract available
NAYAK N, Pati A, Pavani Y, Sahu S, et al CCL19 (rs3136658) and CCL21 (rs2812377) Variants Are Associated With
Susceptibility and Related Mortality of SARS-CoV-2 Infection.
J Infect Dis. 2023;228:101-102. PubMed
RAMILO O, Rodriguez-Fernandez R, Mejias A Respiratory Syncytial Virus Infection: Old Challenges and New Approaches.
J Infect Dis. 2023;228:4-7. PubMed
FUJITA S, Uriu K, Pan L, Nao N, et al Impact of imprinted immunity induced by mRNA vaccination in an experimental
animal model.
J Infect Dis. 2023 Jun 27:jiad230. doi: 10.1093. PubMedAbstract available
ARTENIE A, Stone J, Facente SN, Fraser H, et al Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex
With Men and Who Inject Drugs in San Francisco: A Modelling Analysis.
J Infect Dis. 2023 Jun 24:jiad169. doi: 10.1093. PubMedAbstract available
RODRIGUES TS, Caetano CCS, de Sa KSG, Almeida L, et al CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation.
J Infect Dis. 2023;227:1364-1375. PubMedAbstract available
DEYOE JE, Kelly JD, Grijalva CG, Bonenfant G, et al Association of Culturable-Virus Detection and Household Transmission of
SARS-CoV-2, California and Tennessee, 2020-2022.
J Infect Dis. 2023;227:1343-1347. PubMedAbstract available
SCHIFFER JT The Continuing Puzzle of Defining Duration of Severe Acute Respiratory Syndrome
Coronavirus 2 Infectivity.
J Infect Dis. 2023;227:1339-1342. PubMed
LEE KH, Won D, Kim J, Lee JA, et al Clinical Accuracy and Utility of Plasma Microbial Cell-Free DNA Whole-Genome
Sequencing for the Diagnosis of Invasive Aspergillosis in Patients with
Hematologic Malignancies or Coronavirus Disease 2019.
J Infect Dis. 2023 Jun 15:jiad213. doi: 10.1093. PubMedAbstract available
ZHOU S, Long N, Moeser M, Hill CS, et al Use of Next Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance:
Impact of the SARS-CoV-2 Pandemic on HIV-1 Diagnosis and Transmission.
J Infect Dis. 2023 Jun 7:jiad211. doi: 10.1093. PubMedAbstract available
WANG W, Goguet E, Paz Padilla S, Vassell R, et al Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that
responses to divergent variants would be improved with matched vaccine antigens.
J Infect Dis. 2023 Jun 6:jiad111. doi: 10.1093. PubMedAbstract available
BROWN JA, Hauser A, Abela IA, Pasin C, et al Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in
an HIV cohort in Lesotho: correlates of antibody response and seropositivity.
J Infect Dis. 2023 Jun 1:jiad197. doi: 10.1093. PubMedAbstract available
May 2023
KEELEY AJ, Groves D, Armitage EP, Senghore E, et al Streptococcus pyogenes colonization in children aged 24-59 months in The Gambia:
Impact of Live Attenuated Influenza Vaccine and associated serological responses.
J Infect Dis. 2023 May 29:jiad153. doi: 10.1093. PubMedAbstract available
SCHIFANELLA L, Anderson J, Wieking G, Southern PJ, et al The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and
Necroptosis, Pyroptosis, and PANoptosis.
J Infect Dis. 2023;227:1245-1254. PubMedAbstract available
BAKSH SN, Heath SL, Fukuta Y, Shade D, et al Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent
Plasma for Coronavirus Disease 2019: A Randomized Trial.
J Infect Dis. 2023;227:1266-1273. PubMedAbstract available
FRIES L, Formica N, Mallory RM, Zhou H, et al Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are
Established by NVX-CoV2373 SARS-CoV-2 Primary Vaccination.
J Infect Dis. 2023 May 21:jiad163. doi: 10.1093. PubMedAbstract available
XIA X, Tan ZM, Wan P, Zheng H, et al Environmental impact assessment for the use of an orally aerosolised adenovirus
type-5 vector-based COVID-19 vaccine in randomised clinical trials.
J Infect Dis. 2023 May 18:jiad134. doi: 10.1093. PubMedAbstract available
FORTE-SOTO P, Albayaty M, Brooks D, Arends RH, et al Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute
Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442
(Tixagevimab-Cilgavimab) in Healthy Adults.
J Infect Dis. 2023;227:1153-1163. PubMedAbstract available
LAWLESS D, McKennan CG, Das SR, Junier T, et al Viral Genetic Determinants of Prolonged Respiratory Syncytial Virus Infection
Among Infants in a Healthy Term Birth Cohort.
J Infect Dis. 2023;227:1194-1202. PubMedAbstract available
SU W, Choy KT, Gu H, Sia SF, et al Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2
Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus
2 D614G Variant in Syrian Hamsters.
J Infect Dis. 2023;227:1143-1152. PubMedAbstract available
DURSTENFELD MS, Peluso MJ, Kaveti P, Hill C, et al Reduced exercise capacity, chronotropic incompetence, and early systemic
inflammation in cardiopulmonary phenotype Long COVID.
J Infect Dis. 2023 May 11:jiad131. doi: 10.1093. PubMedAbstract available
ASSANTACHAI P, Niyomnaitham S, Chatthanawaree W, Intalapaporn S, et al Immunogenicity and reactogenicity of mRNA COVID-19 vaccine booster administered
by intradermal or intramuscular route in Thai Older adults.
J Infect Dis. 2023 May 4:jiad133. doi: 10.1093. PubMedAbstract available
April 2023
TAMAI M, Taba S, Mise T, Yamashita M, et al Ethanol vapor inhalation treatment inhibits lethal respiratory viral infection
with Influenza A.
J Infect Dis. 2023 Apr 27:jiad089. doi: 10.1093. PubMedAbstract available
SINGH G, Abbad A, Tcheou J, Mendu DR, et al Binding and avidity signatures of polyclonal sera from individuals with different
exposure histories to SARS-CoV-2 infection, vaccination, and Omicron breakthrough
infections.
J Infect Dis. 2023 Apr 27:jiad116. doi: 10.1093. PubMedAbstract available
IONESCU IG, Skowronski DM, Sauvageau C, Chuang E, et al BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute
Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12-17 Years, by Dosing
Interval and Duration.
J Infect Dis. 2023;227:1073-10783. PubMedAbstract available
VAN DER MAADEN T, Mutubuki EN, de Bruijn S, Leung KY, et al Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2
Compared to Test-Negative and Population Controls in the Netherlands.
J Infect Dis. 2023;227:1059-1067. PubMedAbstract available
KOBAYASHI H, Mori Y, Ahmed S, Hirao Y, et al Oxidative DNA Damage by N4-hydroxycytidine, a Metabolite of the SARS-CoV-2
Antiviral Molnupiravir.
J Infect Dis. 2023;227:1068-1072. PubMedAbstract available
ALVAREZ-HEREDIA P, Reina-Alfonso I, Dominguez-Del Castillo JJ, Gutierrez-Gonzalez C, et al Accelerated T cell immunosenescence in CMV-seropositive individuals after
SARS-CoV-2 infection.
J Infect Dis. 2023 Apr 26:jiad119. doi: 10.1093. PubMedAbstract available
HOEVE CE, de Gier B, Huiberts AJ, de Melker HE, et al Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and
infectiousness within households in the Netherlands between July 2021 and August
2022.
J Infect Dis. 2023 Apr 24:jiad110. doi: 10.1093. PubMedAbstract available
JORDAN E, Kabir G, Schultz S, Silbernagl G, et al Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: a Human
Challenge Trial of MVA-BN-RSV Vaccine.
J Infect Dis. 2023 Apr 20:jiad108. doi: 10.1093. PubMedAbstract available
RAN S, Yao J, Liu B Association Between Coronavirus Disease 2019 and Lung Function: A Mendelian
Randomization Analysis.
J Infect Dis. 2023;227:1019-1020. PubMed
HWANG HS, Lo CM, Murphy M, Grudda T, et al Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During
Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain
Reaction.
J Infect Dis. 2023;227:981-992. PubMedAbstract available
PRASAD N, Rhodes J, Deng L, McCarthy NL, et al Changes in the Incidence of Invasive Bacterial Disease During the COVID-19
Pandemic in the United States, 2014-2020.
J Infect Dis. 2023;227:907-916. PubMedAbstract available
TENFORDE MW, Devine OJ, Reese HE, Silk BJ, et al Point Prevalence Estimates of Activity-Limiting Long-term Symptoms Among United
States Adults >/=1 Month After Reported Severe Acute Respiratory Syndrome
Coronavirus 2 Infection, 1 November 2021.
J Infect Dis. 2023;227:855-863. PubMedAbstract available
TIMI P, Kellerhals SE, Joseph NT, Dude CM, et al Placental Injury and Antibody Transfer after Coronavirus Disease 2019 in
Pregnancy.
J Infect Dis. 2023;227:850-854. PubMedAbstract available
BLANKSON JN Bivalent COVID Vaccines; Can the Original Antigenic Sin be Forgiven?
J Infect Dis. 2023 Apr 5:jiad073. doi: 10.1093. PubMed
TANG L, Wang FZ, Rodewald LE, Wang XY, et al Real-world effectiveness of primary series and booster doses of inactivated
COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective
cohort study.
J Infect Dis. 2023 Apr 3:jiad090. doi: 10.1093. PubMedAbstract available
March 2023
WINCHESTER NE, Shrestha NK, Kim P, Tereshchenko LG, et al Protection Conferred by Delta and BA.1/BA.2 Infection Against BA.4/BA.5 Infection
and Hospitalization: A Retrospective Cohort Study.
J Infect Dis. 2023;227:800-805. PubMedAbstract available
CHU Y, Milner J, Lamb M, Maryamchik E, et al Manufacture and Characterization of Good Manufacturing Practice-Compliant
SARS-COV-2 Cytotoxic T Lymphocytes.
J Infect Dis. 2023;227:788-799. PubMedAbstract available
THOUVENIN G, Prevost B, Corvol H Omicron Wave Modification of the Coronavirus Disease 2019 Paradigm in Children
With Cystic Fibrosis.
J Infect Dis. 2023;227:831-832. PubMed
NURMI V, Knight C, Estcourt L, Hepojoki J, et al The relationship between SARS-CoV-2 neutralising antibody titres and avidity in
plasma collected from convalescent non-vaccinated and vaccinated blood donors.
J Infect Dis. 2023 Mar 27:jiad070. doi: 10.1093. PubMedAbstract available
SMITH CL, Bednarchik B, Aung H, Wilk DJ, et al Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent
Influenza Vaccine in Older Nursing Home Residents.
J Infect Dis. 2023 Mar 23:jiad071. doi: 10.1093. PubMedAbstract available
SUN P, Balinsky CA, Jiang L, Jani V, et al Antibody Responses to the SARS-CoV-2 Ancestral Strain and Omicron Variants in
Moderna mRNA-1273 Vaccinated Active-Duty U.S. Navy Sailors and Marines.
J Infect Dis. 2023 Mar 1:jiad054. doi: 10.1093. PubMedAbstract available
February 2023
CORTESE MM, Taylor AW, Akinbami LJ, Thames-Allen A, et al Surveillance for multisystem inflammatory syndrome in U.S. children aged 5-11
years who received Pfizer-BioNTech COVID-19 vaccine, November 2021-March 2022.
J Infect Dis. 2023 Feb 23:jiad051. doi: 10.1093. PubMedAbstract available
BOZIO CH, Butterfield KA, Briggs Hagen M, Grannis S, et al Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against
COVID-19-associated encounters in adults during Delta and Omicron predominance.
J Infect Dis. 2023 Feb 18:jiad040. doi: 10.1093. PubMedAbstract available
HUAPAYA JA, Higgins J, Kanth S, Demirkale C, et al Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2
Breakthrough Infections.
J Infect Dis. 2023 Feb 18:jiad045. doi: 10.1093. PubMedAbstract available
ALTHAUS T, Landier J, Zhu F, Raps H, et al The impact of SARS-CoV-2 vaccination and infection on neutralising antibodies: a
nation-wide cross-sectional analysis.
J Infect Dis. 2023 Feb 14:jiad030. doi: 10.1093. PubMedAbstract available
DESANTIS SM, Yaseen A, Hao T, Leon-Novelo L, et al Incidence and predictors of breakthrough and severe breakthrough infections of
SARS-CoV-2 after primary series vaccination in adults: A population-based survey
of 22,575 participants.
J Infect Dis. 2023 Feb 2:jiad020. doi: 10.1093. PubMedAbstract available
BEBIA Z, Reyes O, Jeanfreau R, Kantele A, et al Safety and immunogenicity of an investigational respiratory syncytial virus
vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial.
J Infect Dis. 2023 Feb 1:jiad024. doi: 10.1093. PubMedAbstract available
December 2022
NAKAGAMA Y, Candray K, Kaku N, Komase Y, et al Antibody avidity maturation, following recovery from infection or the booster
vaccination, grants breadth in SARS-CoV-2 neutralizing capacity.
J Infect Dis. 2022 Dec 22:jiac492. doi: 10.1093. PubMedAbstract available
DIEZ-DOMINGO J, Saez-Llorens X, Rodriguez-Weber MA, Epalza C, et al Safety and immunogenicity of a ChAd155-vectored RSV vaccine (ChAd155-RSV) in
healthy RSV-seropositive children 12-23 months of age.
J Infect Dis. 2022 Dec 9:jiac481. doi: 10.1093. PubMedAbstract available
SHIODA K, Chen Y, Collins MH, Lopman BA, et al Population-Level Relative Effectiveness of the COVID-19 Vaccines and the
Contribution of Naturally Acquired Immunity.
J Infect Dis. 2022 Dec 7:jiac483. doi: 10.1093. PubMedAbstract available
GREWAL R, Nguyen L, Buchan SA, Wilson SE, et al Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA
Vaccine among Long-Term Care Residents in Ontario, Canada.
J Infect Dis. 2022 Dec 3:jiac468. doi: 10.1093. PubMedAbstract available
November 2022
WANG X, Zein J, Ji X, Lin DY, et al Impact of Vaccination, Prior Infection and Therapy on Omicron Infection and
Mortality.
J Infect Dis. 2022 Nov 23:jiac460. doi: 10.1093. PubMedAbstract available
DESILVA MB, Mitchell PK, Klein NP, Dixon BE, et al Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults
Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.
J Infect Dis. 2022 Nov 23:jiac458. doi: 10.1093. PubMedAbstract available
TOMETTEN I, Landmann S, Kantauskaite M, Lamberti J, et al Factors associated with vaccine-induced T cell immune responses against
SARS-CoV-2 in kidney transplant recipients.
J Infect Dis. 2022 Nov 21:jiac449. doi: 10.1093. PubMedAbstract available
LIND ML, Copin R, McCarthy S, Coppi A, et al Use of whole genome sequencing to estimate the contribution of immune evasion and
waning immunity on decreasing COVID-19 vaccine effectiveness.
J Infect Dis. 2022 Nov 21:jiac453. doi: 10.1093. PubMedAbstract available
JONGKEES MJ, Geers D, Hensley KS, Huisman W, et al Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with
HIV with hyporesponse after primary vaccination.
J Infect Dis. 2022 Nov 19:jiac451. doi: 10.1093. PubMedAbstract available
July 2022
LEROUX-ROELS I, Davis MG, Steenackers K, Essink B, et al Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3)
candidate vaccine in older adults: phase I/II randomized clinical trial.
J Infect Dis. 2022 Jul 29. pii: 6651941. doi: 10.1093. PubMedAbstract available
CRISTINA CASSETTI M, Pierson TC, Jean Patterson L, Bok K, et al Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A
Critical Component of the NIAID Plan for Pandemic Preparedness.
J Infect Dis. 2022 Jul 25. pii: 6649664. doi: 10.1093. PubMedAbstract available
COSSU MV, Mileto D, Giacomelli A, Oreni L, et al Does the co-morbidity burden contribute to suboptimal immunological responses to
COVID-19 vaccination in people living with HIV?
J Infect Dis. 2022 Jul 7. pii: 6633353. doi: 10.1093. PubMed
June 2022
JACOBSON JM Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two
Pandemics.
J Infect Dis. 2022 Jun 7. pii: 6603522. doi: 10.1093. PubMed
LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al People with HIV receiving suppressive antiretroviral therapy show typical
antibody durability after dual COVID-19 vaccination, and strong third dose
responses.
J Infect Dis. 2022 Jun 7. pii: 6603521. doi: 10.1093. PubMedAbstract available